Followers | 839 |
Posts | 120734 |
Boards Moderated | 13 |
Alias Born | 09/05/2002 |
Thursday, May 02, 2024 4:22:37 PM
https://www.businesswire.com/news/home/20240502260564/en
VIR re-iterated guidance for 2024 operating expenses of $650-680M.
CC slides:
https://investors.vir.bio/files/doc_financials/2024/q1/Vir-Corporate-Presentation_Q1-2024.pdf
“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”
Recent VIR News
- Vir Biotechnology Announces Positive End-of-Treatment Results for Tobevibart and Elebsiran Combinations in Chronic Hepatitis B from the MARCH Study at AASLD The Liver Meeting • Business Wire • 11/15/2024 04:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/08/2024 12:20:55 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 11/06/2024 09:55:44 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/05/2024 10:51:48 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 11/05/2024 09:23:50 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/04/2024 09:09:50 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2024 08:20:26 PM
- Vir Biotechnology Reports Third Quarter 2024 Financial Results and Provides Corporate Update • Business Wire • 10/31/2024 08:05:00 PM
- Vir Biotechnology to Provide Business Update and Report Third Quarter 2024 Financial Results on October 31, 2024 • Business Wire • 10/17/2024 08:30:00 PM
- Vir Biotechnology Announces Clinical Advances Across Hepatitis Delta and Hepatitis B Programs at AASLD’s The Liver Meeting® 2024 • Business Wire • 10/15/2024 12:16:00 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 10/03/2024 09:11:54 PM
- Vir Biotechnology to Participate in the H.C. Wainwright 5th Annual Viral Hepatitis Virtual Conference • Business Wire • 10/03/2024 08:00:00 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 10/02/2024 04:09:07 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 10/02/2024 04:07:26 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/10/2024 08:28:47 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/10/2024 12:10:48 PM
- Vir Biotechnology Appoints Jason O’Byrne as Chief Financial Officer • Business Wire • 09/10/2024 12:05:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 09/09/2024 08:29:38 PM
- Vir Biotechnology Announces Closing of Exclusive Worldwide License Agreement With Sanofi for Multiple Potential Best-in-Class Clinical-Stage T-Cell Engagers • Business Wire • 09/09/2024 08:05:00 PM
- Vir Biotechnology to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference • Business Wire • 08/22/2024 12:05:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/01/2024 08:43:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/01/2024 08:10:58 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/01/2024 08:08:53 PM
- Vir Biotechnology Reports Second Quarter 2024 Financial Results and Announces Strategic Restructuring to Prioritize Clinical-Stage Pipeline Opportunities • Business Wire • 08/01/2024 08:02:00 PM
- Vir Biotechnology Acts on Expanded Strategy of Powering the Immune System Through Exclusive Worldwide License Agreement with Sanofi for Multiple Potential Best-in-Class Clinical-Stage T-cell Engagers • Business Wire • 08/01/2024 08:01:00 PM
Kona Gold Beverage, Inc. Updates Multi-Million Dollar Merger and Posts Over $1.2 Million in Q3 Revenues • KGKG • Nov 15, 2024 10:36 AM
HealthLynked Corp. Announces Third Quarter and Year-to-Date 2024 Results with Strategic Restructuring, Third-Party Debt Repayment, and Core Technology Focus • HLYK • Nov 15, 2024 8:00 AM
Alliance Creative Group (ACGX) Releases Q3 2024 Financial and Disclosure Report with an increase of over 100% in Net Income for 1st 9 months of 2024 vs 2023 • ACGX • Nov 14, 2024 8:30 AM
Unitronix Corp. Publishes Its Cryptocurrency Portfolio Strategy • UTRX • Nov 14, 2024 8:05 AM
Avant Technologies and Ainnova Tech Form Joint Venture to Advance Early Disease Detection Using Artificial Intelligence • AVAI • Nov 12, 2024 9:00 AM
Swifty Global Announces Launch of Swifty Sports IE, Expanding Sports Betting and Casino Services in the Irish Market • DRCR • Nov 12, 2024 9:00 AM